K. William Harter

Papers

Total Citations

H-Index

About

K. William Harter is a radiation oncologist whose research focuses on advancing treatment paradigms for prostate cancer, particularly through the integration of intensity-modulated radiation therapy (IMRT) and stereotactic body radiation therapy (SBRT). His major contribution lies in exploring SBRT as a less invasive alternative to brachytherapy for delivering radiation boosts in unfavorable prostate cancer cases. In his most-cited work, a 2017 study reporting on 3-year toxicity outcomes, Harter demonstrated that combining IMRT with an SBRT boost yields promising biochemical relapse-free survival rates while maintaining acceptable toxicity profiles. This research, cited 21 times, has helped shape clinical discussions around non-surgical treatment intensification. Harter’s work is notable for its focus on balancing efficacy with quality of life, addressing a critical need in prostate cancer management. By evaluating long-term outcomes and side effects, he has contributed to evidence supporting SBRT as a practical, patient-friendly option. His findings continue to inform radiation oncology protocols, offering clinicians and researchers valuable data on optimizing dose delivery for aggressive disease while minimizing invasiveness.